Stable CAD (Coronary artery disease)

Latest stable coronary artery disease (stable CAD) content in interventional cardiology - research, practice, and education

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

309 results

EuroPCR 2021 Hotlines / Late-Breaking Trials: PLA-pCi-EBO-pilot, CALM, ISCHEMIA, and more!

26 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in stable CAD:

  • Effects of visualization of PCI results on symptoms in chronic coronary syndrome
  • Effect of Atorvastatin Therapy on Serial Changes of Coronary Flow And Plaque
  • Initial results of a feasibility study of endovascular baroreflex amplification in heart failure patients
  • Impact...
EuroPCR 2021 Hotlines / Late-Breaking Trials: PLA-pCi-EBO-pilot, CALM, ISCHEMIA, and more!

Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial

27 May 2021

ISCHEMIA-CKD is the only contemporary randomized trial that prospectively evaluated an upfront strategy of coronary angiography and revascularization plus optimal medical therapy (OMT) compared with OMT alone in patients listed for renal transplant.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial

A randomised study comparing imaging guided implantation of Orsiro and Xience - CASTLE study

20 May 2021 – From EuroPCR 2021

Watch this LBT session, which was originally presented during EuroPCR 2021, to find out more about the CASTLE study, whose aim is to access the results of two types of DES implanted with image guidance in all-comers.

A randomised study comparing imaging guided implantation of Orsiro and Xience - CASTLE study

Short DAPT in high bleeding risk: ready for prime time?

20 May 2021 – From EuroPCR 2021

Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...

Short DAPT in high bleeding risk: ready for prime time?

EuroIntervention - Most discussed papers of the year

19 May 2021 – From EuroPCR 2021

Watch this session if you want to know the top 3 most discussed papers of the year which concern management of myocardial revascularisation failure, the impact of COVID-19 pandemic on interventional cardiology practice and Ischaemia witch non-obstructive coronary arteries.

This session was originally presented during EuroPCR 2021.

EuroIntervention - Most discussed papers of the year

Top Interventional Trials presented at ACC.21

07 Jun 2021

Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21

Ali Nazmi Calik

Author

Ali Nazmi Calik
Top Interventional Trials presented at ACC.21

Is angio-based FFR ready to replace invasive FFR?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen and Ziad Ali in order to know more about physiological assessment in the cathlab and angio-based vFFR, the results of the multicentre vFFR clinical trial, and the future of angio-based FFR in the cathlab.

Is angio-based FFR ready to replace invasive FFR?

Meta-analysis of elective coronary revascularization vs medical therapy alone

18 May 2021 – From EuroPCR 2021

This session, originally broadcast during EuroPCR 2021, presents a meta-analysis based on 25 trials dealing with revascularization in patients with chronic coronary syndromes and enables our experts to discuss the strengths and weaknesses of this study.  

Meta-analysis of elective

Diffuse Coronary Artery Disease: RESTORE DCB – THE HYPER STUDY

18 May 2021 – From EuroPCR 2021

Watch this session presented by Alfonso Lelasi in order to have an update on the treatment of diffuse CAD involving small vessels and/or bifurcation with a novel hybrid (DES and DCB) approach, to understand the rationale of The HYPER Study (NCT03939468), and to know more about third generation RESTORE...

Diffuse Coronary Artery Disease: RESTORE DCB – THE HYPER STUDY

EuroIntervention - Most cited papers of the year 2020

18 May 2021 – From EuroPCR 2021

Thanks to this session, which was originally presented during EuroPCR 2021, by D. Capodanno, Editor-in-chief, and N. Gonzalo & D. Mylotte, deputy editors, discover the top 3 most cited EuroIntervention Journal papers in 2020, and hear the reaction of the winner, interviewed for the occasion.

EuroIntervention - Most cited papers of the year 2020